Clinical Trials

A Study Comparing CyberKnife Surgery with Brachytherapy in Prostate Cancer Patients

Number: NCT01045148
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): CyberKnife Centers of San Diego
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study to evaluate immunotherapy in combination with radiation in prostate cancer patients

Number: NCT01436968
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): Advantagene, Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s)
Evaluate the response of the cancer and side effects of radiation to pelvic lymph nodes and to the prostate

Number: NCT02177292
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Medical College of Wisconsin
Sponsor Trial Information
Trial Location(s) and Contact(s)
High-Dose Brachytherapy in Treating Patients With Prostate Cancer

Number: NCT02346253
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1/2
Sponsor(s): Stanford University|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Phase 1/2 Study of In Situ Vaccination With Tremelimumab and IV Durvalumab Plus PolyICLC in Subjects With Advanced, Measurable, Biopsy-accessible Cancers

Number: NCT02643303
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1|Phase 2
Sponsor(s): Ludwig Institute for Cancer Research|MedImmune LLC|Cancer Research Institute, New York City
Sponsor Trial Information
Trial Location(s) and Contact(s)
68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery

Number: NCT02678351
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2/3
Sponsor(s): Andrei Iagaru|National Cancer Institute (NCI)|Stanford University
Sponsor Trial Information
Trial Location(s) and Contact(s)
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

Number: NCT02713269
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): M.D. Anderson Cancer Center|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
ARN-509 and Leuprolide in Intermediate and High-risk Prostate Cancer

Number: NCT02770391
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Case Comprehensive Cancer Center
Sponsor Trial Information
Trial Location(s) and Contact(s)
Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies

Number: NCT02913131
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1/2
Sponsor(s): Rahul Aggarwal|National Institutes of Health (NIH)|National Cancer Institute (NCI)|University of California, San Francisco
Sponsor Trial Information
Trial Location(s) and Contact(s)
Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate

Number: NCT02944201
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Montefiore Medical Center|Albert Einstein College of Medicine
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Number: NCT02946996
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Medical University of South Carolina
Sponsor Trial Information
Trial Location(s) and Contact(s)
Apalutamide With or Without Abiraterone, Hormone, and Prednisone in Treating High-Risk Patients Undergoing Surgery

Number: NCT02949284
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Rutgers, The State University of New Jersey|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Number: NCT02960022
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Astellas Pharma Global Development, Inc.|Pfizer|Astellas Pharma Inc
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Study of Androgen Treatment in High-Risk Biochemically Relapsed Prostate Cancer

Number: NCT03009981
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: 3
Sponsor(s): Alliance Foundation Trials, LLC.|Janssen Research & Development, LLC
Sponsor Trial Information
Trial Location(s) and Contact(s)
Clinical Study of change in brain structure or activity in men treated with androgen receptor therapies such as abiraterone acetate and enzalutamide

Number: NCT03016741
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 4
Sponsor(s): Northwestern University
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of Olaparib in Men With High-Risk Recurrent Prostate Cancer Following Prostate Surgery

Number: NCT03047135
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sponsor Trial Information
Trial Location(s) and Contact(s)
Treatment with Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer

Number: NCT03069937
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Medical University of South Carolina|Ferring Pharmaceuticals
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Study to Evaluate Relugolix in Men With Advanced Prostate Cancer

Number: NCT03085095
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): Myovant Sciences GmbH
Sponsor Trial Information
Trial Location(s) and Contact(s)
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer

Number: NCT03113617
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Andrei Iagaru|Stanford University
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Subjects With Locally Advanced or Metastatic Solid Tumors

Number: NCT03150810
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1|Phase 2
Sponsor(s): BeiGene|Myriad Genetics, Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Number: NCT03170960
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Exelixis
Sponsor Trial Information
Trial Location(s) and Contact(s)
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Number: NCT03181867
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

Number: NCT03333616
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Dana-Farber Cancer Institute|Bristol-Myers Squibb
Sponsor Trial Information
Trial Location(s) and Contact(s)
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Hormone-Sensitive Prostate Cancer Previously Treated With Docetaxel

Number: NCT03419234
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group
Sponsor Trial Information
Trial Location(s) and Contact(s)
To evaluate whether olaparib can reduce prostate cancer with defects in DNA repair genes when olaparib is given for approximately 3 months before surgery

Number: NCT03432897
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Dr Anthony Mega|Rhode Island Hospital|The Miriam Hospital|AstraZeneca|Brown University
Sponsor Trial Information
Trial Location(s) and Contact(s)
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

Number: NCT03436654
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Memorial Sloan Kettering Cancer Center|Dana-Farber Cancer Institute
Sponsor Trial Information
Trial Location(s) and Contact(s)
Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer

Number: NCT03439033
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Weill Medical College of Cornell University
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer

Number: NCT03471650
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Progenics Pharmaceuticals, Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s)
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Number: NCT03541850
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

Number: NCT03541928
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): The Methodist Hospital System
Sponsor Trial Information
Trial Location(s) and Contact(s)
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer

Number: NCT03565835
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Montefiore Medical Center
Sponsor Trial Information
Trial Location(s) and Contact(s)
Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations

Number: NCT03570619
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Michigan Cancer Center|Memorial Sloan Kettering Cancer Center|University of California, San Francisco
Sponsor Trial Information
Trial Location(s) and Contact(s)
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer

Number: NCT03581500
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): M.D. Anderson Cancer Center|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Number: NCT03678025
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): Southwest Oncology Group|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

Number: NCT03706365
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Eli Lilly and Company
Sponsor Trial Information
Trial Location(s) and Contact(s)
Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone

Number: NCT03707184
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Utah
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer (MAGNITUDE)

Number: NCT03748641
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): Janssen Research & Development, LLC
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Study of Pembrolizumab Plus Androgen Receptor Targeting Prior to Prostatectomy for High Risk Patients

Number: NCT03753243
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: 2
Sponsor(s): Merck Sharp & Dohme Corp.|Astellas Pharma Inc|Portland VA Medical Center
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Study of Apalutamide in Participants With High Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

Number: NCT03767244
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): Janssen Research & Development, LLC
Sponsor Trial Information
Trial Location(s) and Contact(s)
Conventional ADT w/ or w/Out Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT

Number: NCT03777982
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): Dana-Farber Cancer Institute|Janssen Scientific Affairs, LLC
Sponsor Trial Information
Trial Location(s) and Contact(s)
MRI Guided SBRT for Localized Prostate Cancer

Number: NCT03778112
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Rush University Medical Center
Sponsor Trial Information
Trial Location(s) and Contact(s)
Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)

Number: NCT03787680
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Michigan Rogel Cancer Center
Sponsor Trial Information
Trial Location(s) and Contact(s)
(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes

Number: NCT03796195
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 4
Sponsor(s): Northwestern University
Sponsor Trial Information
Trial Location(s) and Contact(s)
Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients

Number: NCT03803475
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): Thomas Hope|University of California, San Francisco
Sponsor Trial Information
Trial Location(s) and Contact(s)
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

Number: NCT03821792
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): M.D. Anderson Cancer Center|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer

Number: NCT03824275
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2/3
Sponsor(s): Columbia University
Sponsor Trial Information
Trial Location(s) and Contact(s)
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer

Number: NCT03833921
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Martha Mims|Baylor College of Medicine
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.

Number: NCT03840200
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1|Phase 2
Sponsor(s): Hoffmann-La Roche
Sponsor Trial Information
Trial Location(s) and Contact(s)
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

Number: NCT03860987
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer

Number: NCT03886493
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Regeneron Pharmaceuticals
Sponsor Trial Information
Trial Location(s) and Contact(s)
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery

Number: NCT03899987
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Roswell Park Cancer Institute|National Cancer Institute (NCI)|Hemispherx Biopharma
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Trial of BXCL701 and Pembrolizumab in Patients With Small Cell Neuroendocrine Prostate Cancer

Number: NCT03910660
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1|Phase 2
Sponsor(s): BioXcel Therapeutics Inc
Sponsor Trial Information
Trial Location(s) and Contact(s)
REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer

Number: NCT03951831
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Mark Stein|Regeneron Pharmaceuticals|Columbia University
Sponsor Trial Information
Trial Location(s) and Contact(s)
Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer

Number: NCT03964337
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Duke University|Exelixis
Sponsor Trial Information
Trial Location(s) and Contact(s)
Prostate Specific Membrane Antigen (PSMA)-Based PET Imaging of High Risk Prostate Cancer

Number: NCT03976843
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer

Number: NCT03987386
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): M.D. Anderson Cancer Center|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer

Number: NCT03999515
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Washington|National Cancer Institute (NCI)|Janssen Research & Development, LLC
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer

Number: NCT04019327
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1/2
Sponsor(s): Memorial Sloan Kettering Cancer Center
Sponsor Trial Information
Trial Location(s) and Contact(s)
Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer

Number: NCT04020094
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Utah|Bavarian Nordic|Genentech, Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s)
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects

Number: NCT04030559
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of California, Davis|National Cancer Institute (NCI)|Janssen, LP
Sponsor Trial Information
Trial Location(s) and Contact(s)
Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer

Number: NCT04037254
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): NRG Oncology|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers

Number: NCT04037358
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sponsor Trial Information
Trial Location(s) and Contact(s)
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer

Number: NCT04050215
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

Number: NCT04126070
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Xiao X. Wei|Bristol-Myers Squibb|Dana-Farber Cancer Institute
Sponsor Trial Information
Trial Location(s) and Contact(s)
An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer

Number: NCT04134208
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 4
Sponsor(s): M.D. Anderson Cancer Center|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Testing the Addition of the Drugs, Apalutamide and Abiraterone Acetate With Prednisone, to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer

Number: NCT04134260
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): NRG Oncology|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC)

Number: NCT04157088
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Bayer
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Study to Evaluate Rucaparib in Patients With Solid Tumors and With Deleterious Mutations in HRR Genes

Number: NCT04171700
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Clovis Oncology, Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s)
Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer (LIGHTHOUSE)

Number: NCT04186819
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): Blue Earth Diagnostics|Parexel
Sponsor Trial Information
Trial Location(s) and Contact(s)
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)

Number: NCT04191096
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): Merck Sharp & Dohme Corp.
Sponsor Trial Information
Trial Location(s) and Contact(s)
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer

Number: NCT04253483
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Rutgers, The State University of New Jersey|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of Abiraterone Acetate, Atezolizumab, Lupron, and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

Number: NCT04262154
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Memorial Sloan Kettering Cancer Center|Genentech, Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s)
Apalutamide, Abiraterone Acetate, and Prednisone for the Treatment of Metastatic High Risk Castration Sensitive Prostate Cancer

Number: NCT04267887
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): OHSU Knight Cancer Institute|National Cancer Institute (NCI)|Oregon Health and Science University
Sponsor Trial Information
Trial Location(s) and Contact(s)
18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer

Number: NCT04390880
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): VA Greater Los Angeles Healthcare System
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer

Number: NCT04402151
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Weill Medical College of Cornell University|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)

Total: 75 Clinical Trials





PHEN,Inc. © 2020 All rights reserved